重新评估Halm临床稳定性标准在社区获得性肺炎管理中的应用
本研究基于丹麦三家医院2017至2020年2918例免疫正常的社区获得性肺炎住院患者,评估Halm临床稳定性标准在当代真实世界中的适用性。结果显示,达到Halm标准的中位时间为4天,早期临床应答者中约五分之一出现不稳定复发,30天内严重并发症主要为死亡。结论认为该标准能有效区分不同病程,但老年共病人群达标需更长时间。
要点
- Halm标准中位达标时间为4天,老年共病人群达标更慢。
- 早期临床应答者中约五分之一出现不稳定复发。
- 早期临床应答且无DNR医嘱者30天严重并发症风险较低。
核心结论
- Halm临床稳定性标准能有效区分CAP患者的不同病程。
- 在老年、共病多且病情较重的当代人群中,达到稳定性所需时间更长。
- 早期临床应答提示并发症风险降低,尤其在无DNR医嘱者中。
研究设计与样本
- 队列研究,纳入丹麦三家医院2017至2020年2918例免疫正常的CAP住院患者。
- 主要结局为按Halm标准达到临床稳定的时间,并分析不稳定复发和严重并发症。
- 采用累积发病率函数或Kaplan-Meier生存曲线分析,考虑竞争风险。
主要发现
- 研究人群以老年人为主(中位年龄75岁),共病显著。
- 按Halm标准达到临床稳定的中位时间为4天。
- 早期临床应答(3天内稳定)者中五分之一出现不稳定复发。
- 30天内严重并发症主要为死亡,早期临床应答者总体发生率为5.1%(64/1257)。
- 早期临床应答者中,无DNR医嘱亚组严重并发症发生率为1.7%(18/1045),其余为17.3%(276/1595)。
关键数值与推荐
- Halm临床稳定性标准:原文未列出具体条款。
- 早期临床应答定义为3天内达到稳定。
- 严重并发症发生率:早期临床应答者总体5.1%(64/1257),无DNR医嘱亚组1.7%(18/1045),其余17.3%(276/1595)。
临床怎么用
- 在老年共病CAP患者中应用Halm标准时,应预期达标可能需要4天或更久。
- 对3天内早期临床应答者仍需警惕不稳定复发。
- 早期临床应答且无DNR医嘱者并发症风险较低,可辅助临床决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Halm's clinical stability criteria have long guided antibiotic treatment and hospital discharge decisions for patients hospitalised with community-acquired pneumonia (CAP). Originally introduced in 1998, these criteria were established based on a relatively small and select patient population. Consequently, our study aims to reassess their applicability in the management of CAP in a contemporary real-world setting. METHODS: This cohort study included 2918 immunocompetent patients hospitalised with CAP from three hospitals in Denmark between 2017 and 2020. The primary outcome was time to achieve clinical stability as defined by Halm's criteria. Additionally, we examined recurrence of clinical instability and severe complications. Cumulative incidence function or Kaplan-Meier survival curves were used to analyse these outcomes, considering competing risks. RESULTS: The study population primarily comprised elderly individuals (median age 75 years) with significant comorbidities. The median time to clinical stability according to Halm's criteria was 4 days, with one-fifth experiencing recurrence of instability after early clinical response (stability within 3 days). Severe complications within 30 days mainly comprised mortality, with rates of 5.1% (64/1257) overall in those with early clinical response, 1.7% (18/1045) in the subgroup without do-not-resuscitate orders and 17.3% (276/1595) among the rest. CONCLUSION: Halm's clinical stability criteria effectively classify CAP patients with different disease courses, yet achieving stability required more time in this ageing population with substantial comorbidities and more severe disease. Early clinical response indicates reduced risk of complications, especially in those without do-not-resuscitate orders.
引用
- Bastrup Israelsen, Fally, Brok Nielsen, et al. Reassessing Halm's clinical stability criteria in community-acquired pneumonia management. Eur Respir J. 2024. PMID: 39174283. doi:10.1183/13993003.00054-2024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。